Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypanothione is a unique thiol metabolite found in certain protozoan parasites (Kinetoplastida), where it serves as a major antioxidant and electron donor for multiple redox-active enzymes. It consists of two glutathione molecules linked by a spermidine polyamine, enabling these organisms to survive oxidative challenges in the host environment. Its enzymes, notably trypanothione reductase, present highly selective drug targets due to absence of the trypanothione pathway in humans. Trypanothione itself is not a protein drug target, but a metabolite central to the parasite’s antioxidant system.
Drugs typically inhibit trypanothione-dependent enzymes such as: Enzyme inhibition (block trypanothione reductase, prevent regeneration of reduced trypanothione, induce oxidative stress in parasite)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypanothione.